Apply now: feature your voice in our cell and gene therapy series
This week's must-know community updates, latest research & events
Adrenal Dysfunction Study
New Drugs for Primary Care in Q4 2024
New Study on Classic CAH Treatment and Management
FDA Approves First New Treatment for Classic Adrenal Disorder in 70 Years
First New Drug for Rare Hormonal Disorder in 70 Years Approved
Biopharma Company Discontinues Drug Trials Following Efficiency Changes
Anastrozole Boosts Height in Children with Adrenal Disorder
New treatment enhances child growth and Genetic screening for newborns
Treatment breakthroughs, case studies, and diagnostic challenges.
Empowering CAH patients: tailored diet, enhanced bone health, and support for lifelong symptom management.
